Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lee A Hebert

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
The New England Journal of Medicine|January 13, 2006
Optimizing ACE-inhibitor therapy for chronic kidney diseaseLee A Hebert
Nephron. Clinical Practice|November 2, 2002
Management of lupus nephropathyLee A Hebert
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2014
Is fluid overload as measured by bioimpedance spectroscopy harmful in CKD-if so, why?Lee A Hebert, Samir Parikh
The New England Journal of Medicine|February 3, 2009
Uric acid and cardiovascular riskLee A Hebert, Brad Rovin
Nature Reviews. Nephrology|September 18, 2013
Chronic kidney disease: fluid in chronic kidney disease-how much is too much?Lee A Hebert, Samir Parikh
Seminars in Nephrology|August 16, 2011
Infection-related glomerulonephritis: understanding mechanismsTibor Nadasdy, Lee A Hebert
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2005
Timed urine collections are not needed to measure urine protein excretion in clinical practiceGanesh Shidham, Lee A Hebert
Seminars in Nephrology|November 18, 2015
The Complement System in Lupus NephritisDaniel J Birmingham, Lee A Hebert
Nephron. Clinical Practice|August 7, 2010
Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care?Lee A Hebert, Brad H Rovin
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2015
In Reply to 'Expanding the Domain of Postinfectious Glomerulonephritis' and 'Postinfectious Versus Infection-Related Glomerulonephritis'Lee A Hebert, Richard J Glassock
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
The New England Journal of Medicine|January 13, 2006
Optimizing ACE-inhibitor therapy for chronic kidney diseaseLee A Hebert
Nephron. Clinical Practice|November 2, 2002
Management of lupus nephropathyLee A Hebert
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2014
Is fluid overload as measured by bioimpedance spectroscopy harmful in CKD-if so, why?Lee A Hebert, Samir Parikh
The New England Journal of Medicine|February 3, 2009
Uric acid and cardiovascular riskLee A Hebert, Brad Rovin
Nature Reviews. Nephrology|September 18, 2013
Chronic kidney disease: fluid in chronic kidney disease-how much is too much?Lee A Hebert, Samir Parikh
Seminars in Nephrology|August 16, 2011
Infection-related glomerulonephritis: understanding mechanismsTibor Nadasdy, Lee A Hebert
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 27, 2005
Timed urine collections are not needed to measure urine protein excretion in clinical practiceGanesh Shidham, Lee A Hebert
Seminars in Nephrology|November 18, 2015
The Complement System in Lupus NephritisDaniel J Birmingham, Lee A Hebert
Nephron. Clinical Practice|August 7, 2010
Oral cyclophosphamide is on the verge of extinction as therapy for severe autoimmune diseases (especially lupus): should nephrologists care?Lee A Hebert, Brad H Rovin
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 27, 2015
In Reply to 'Expanding the Domain of Postinfectious Glomerulonephritis' and 'Postinfectious Versus Infection-Related Glomerulonephritis'Lee A Hebert, Richard J Glassock
Pageof 8